Adam Levy
Equibles does not estimate personal net worth.
About Adam Levy
Adam Levy is recorded as CFO at Acrivon Therapeutics, Inc. (ACRV). The newest filing on record that lists Adam Levy as CFO at Acrivon Therapeutics, Inc. (ACRV) is dated April 30, 2026. Acrivon Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Acrivon Therapeutics, Inc. includes Peter Blume-Jensen (CEO), Adam Levy, Ph.D., M.B.A. (CFO), Eric Devroe (COO) and 5 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 30, 2026
Company network
Leadership on record at Acrivon Therapeutics, Inc.
- Peter Blume-Jensen CEO
- Adam Levy, Ph.D., M.B.A. CFO
- Eric Devroe COO
- Charles Baum, M.D., Ph.D. Board Member
- Ivana Magovcevic-Liebisch, Ph.D., J.D. Board Member
- Kristina Masson Board Member
- Michael Tomsicek, M.B.A. Board Member
- Santhosh Palani, Ph.D., CFA Board Member
Recent activity
No call appearances or filed executive changes recorded yet.